Do You Suffer From Chronic Low Back Pain? Research Study Investigates Stem Cell Treatment
Please note: This trial has finished recruiting and is not accepting new participants.
Research Center: Denver Back Pain Specialists
Location: 7730 E Belleview Ave, Suite A-104, Greenwood Village, CO
Lead Researcher: J. Scott Bainbridge, M.D
Ethics Committee: Reviewed and approved by the Chesapeake Independent Review Board
Many Americans suffer from chronic low back pain. This pain sometimes occurs as a result of normal wear and tear of discs in the spine, often related to aging.
This research study is being conducted to examine the effectiveness of a new investigational medication in reducing chronic low back pain. The medication is made from special stem cells.
This research study seeks men and women aged 18+ who have experienced chronic low back pain for last 6 months or more and have not been able to successfully treat symptoms. Participants are required to attend 9 study visits at the research site over a 36 month period, with the majority of the visits occurring in the first 12 months.
Benefits to Participation
- You may be eligible for time and expense reimbursement for participating in this study
- You may experience pain relief.
- You will receive all study-related materials and procedures at no charge.
- You will be helping to advance medical research.
- If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
- Your records relating to this study and any other information received will be kept strictly confidential.
- Qualified health professionals will monitor your health as it relates to the study.
Who Can Participate?
- Men and women who are 18+ years of age
- Who have experienced chronic back pain for the past 6 months or more and have not successfully treated symptoms
- Not on worker’s compensation
- If female, not pregnant or nursing, or planning to become pregnant
- Willing to attend 9 study visits at the research site over a 36 month period, with the majority of the visits occurring in the first 12 months